Long-Term Disease Control of a Non-Operable Neuroendocrine Tumor of the Lung with Lanreotide: A Case Study

Bronchopulmonary neuroendocrine tumors (NETs) are malignant tumors that represent approximately 20% of all lung cancers. The therapeutic option for advanced or metastatic bronchopulmonary NETs is mainly palliation of symptoms; options need to be individualized and, therefore, rely on the knowledge o...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Fraeyenhove, F., De Droogh, E., Meireson, N., Galdermans, D., Goor, C., Van Acker, F., Mattelaer, C., De Ruyter, V., Schrijvers, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: December, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551439/
https://www.ncbi.nlm.nih.gov/pubmed/23341808
http://dx.doi.org/10.1159/000345695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551439/
https://www.ncbi.nlm.nih.gov/pubmed/23341808
http://dx.doi.org/10.1159/000345695

Ejemplares similares